Cytokines are small secreted ‘messenger proteins’ that allow communication between cells. They contribute to a chemical signalling language that controls many processes in multicellular organisms, including haematopoiesis, chemoattraction, tissue repair, embryogenesis and virtually all aspects of immunity and inflammation. Cytokine functions are mediated by their binding to specific receptors to initiate intracellular signalling cascades that increase or decrease expression of transcription factors and genes regulating, for example, secretion of effector molecules (including other cytokines), cell proliferation and expression of membrane receptors. They play an important role in many pathologies, and indeed measurement of cytokine profiles in patients can provide a useful indicator of disease. Owing to their multiple functions in disease, therapeutic interference with cytokines, cytokine receptors or their signal transduction pathways offers new treatment options for a range of disorders.

Key Concepts:

  • Cytokines can be extremely potent, acting at picomolar or femtomolar concentrations.

  • Cytokines are not produced constitutively but are expressed on stimulation of cells, usually acting in an autocrine or paracrine fashion.

  • Individual cytokines can have many functions and can act synergistically or antagonistically.

  • Chemokines are a family of cytokines that are not only principally involved in chemoattraction but also participate in cell activation and angiogenesis.

  • Different cytokine receptors can share similar subunit structures, which divide them into families.

  • Most cytokine receptors are heterodimers, but some can be homodimers or heterotrimers.

  • Cytokines exert their effects by activating specific intracellular signalling pathways.

  • By sharing receptor subunits and signal transducing molecules, many cytokines are known to play redundant and pleiotropic roles.

  • Excessive cytokine production or activity can lead to several pathologies, and cytokine modifiers are proving to be a therapeutically effective approach in modifying such diseases.

  • Cytokine synthesis and activity is regulated by many mechanisms including signalling inhibitors, epigenetic modifications and cleavage of precursors.

Keywords: cytokines; chemokines; cytokine receptors; cytokine signalling; cytokine/anticytokine therapy

Figure 1.

Receptors for different cytokines are classified into families on the basis of conserved extracellular domain structures and signalling mechanisms. WSXWS, tryptophan‐serine‐X‐tryptophan‐serine.

Figure 2.

Main T‐cell subsets differentiated from naïve T cells. Figure illustrates the importance of cytokines in directing polarisation and determining functional activity.

Figure 3.

Factors determining cytokine secretion and activity.



Annunziato F and Romagnani S (2009) Heterogeneity of human effector CD4+ T cells. Arthritis Research and Therapy 11(6): 257, doi:10.1186/ar2843.

Astry B, Harberts E and Moudgil KD (2011) A cytokine‐centric view of the pathogenesis and treatment of autoimmune arthritis. Journal of Interferon and Cytokine Research 31: 927–940.

Colmegna I, Ohata BR and Menard HA (2012) Current understanding of rheumatoid arthritis therapy. Clinical Pharmacology and Therapeutics 91: 607–620.

Commins SP, Borish L and Steinke JW (2010) Immunologic messenger molecules: cytokines, interferons, and chemokines. Journal of Allergy and Clinical Immunology 125(2 Suppl. 2): S53–S72.

Hashioka S, McGeer PL, Monji A and Kanba S (2009) Anti‐inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease. Central Nervous System Agents in Medicinal Chemistry 9(1): 12–19.

Hirahara K, Vahedi G, Ghoreschi K et al. (2011) Helper T‐cell differentiation and plasticity: insights from epigenetics. Immunology 134(3): 235–245.

Liao W, Lin JX and Leonard WJ (2011) IL‐2 family cytokines: new insights into the complex roles of IL‐2 as a broad regulator of T helper cell differentiation. Current Opinion in Immunology 23(5): 598–604.

Liew FY (2012) IL‐33: a Janus cytokine. Annals of the Rheumatic Diseases 71(Suppl. 2): i101–i104.

Loftis JM, Huckans M and Morasco BJ (2010) Neuroimmune mechanisms of cytokine‐induced depression: current theories and novel treatment strategies. Neurobiology of Disease 37: 519–533.

O'Shea JJ and Plenge R (2012) JAK and STAT signaling molecules in immunoregulation and immune‐mediated disease. Immunity 36: 542–550.

Shirakawa I, Deichmann KA, Izuhara I et al. (2000) Atopy and asthma: genetic variants of IL‐4 and IL‐13 signalling. Immunology Today 21(2): 60–64.

Tincani A, Andreoli L, Bazzani C, Bossiso D and Sozzani S (2007) Inflammatory molecules: a target for treatment of systemic autoimmune diseases. Autoimmunity Reviews 7(1): 1–7.

Weschenfelder J, Sander C, Kluge M, Kirkby KC and Himmerich H (2012) The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems. Psychiatria Danubina 24(2): 112–126.

Zhang JM and An J (2007) Cytokines, inflammation, and pain. International Anesthesiology Clinics 45: 27–37.

Further Reading

Bonjardim CA, Ferreira PC and Kroon EG (2009) Interferons: signalling, antiviral and viral evasion. Immunology Letters 1: 1–11.

Charo IF and Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. New England Journal of Medicine 354: 610–621.

Diveu C, McGeachy MJ and Cua DJ (2008) Cytokines that regulate autoimmunity. Current Opinion in Immunology 20: 663–668.

Donnelly RP, Young HA and Rosenberg AS (2009) An overview of cytokines and cytokine antagonists as therapeutic agents. Annals of the New York Academy of Sciences 1182: 1–13.

Kiu H and Nicholson SE (2012) Biology and significance of the JAK/STAT signalling pathways. Growth Factors 30(2): 88–106.

O'Sullivan LA, Liongue C, Lewis RS, Stephenson SE and Ward AC (2007) Cytokine receptor signaling through the Jak‐Stat‐Socs pathway in disease. Molecular Immunology 44(10): 2497–2506.

Pesu M, Laurence A, Kishore N et al. (2008) Therapeutic targeting of Janus kinases. Immunological Reviews 223: 132–142.

Platanias LC (2005) Mechanisms of type‐I‐ and type‐II‐interferon‐mediated signalling. Nature Reviews Immunology 5: 375–386.

Vilcek J (2003) The cytokines: an overview. In: Lotze M and Thompson AW (eds) The Cytokine Handbook, 4th edn, vol. I, pp. 3–18. Amsterdam: Academic Press.

Zhu J and Paul WE (2008) CD4T cells: fates, functions, and faults. Blood 112: 1557–1569.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Wilson, Heather M, and Barker, Robert N(Feb 2013) Cytokines. In: eLS. John Wiley & Sons Ltd, Chichester. [doi: 10.1002/9780470015902.a0000929.pub3]